MSCI暫不執行從全球指數中剔除5家中國公司
指數編制公司MSCI公司公布,不執行其於1月26日公布的將五家中國公司證券從其ACWI指數系列、中國全股票指數及相關非市值加權指數和定制指數中剔除的決定,當中涉及的股份包括中廣核(01816.HK)、中國化學(601117.SH)、中國核電(601985.SH)、中國重工(601989.SH)、浪潮國際(00596.HK)。
MSCI指,獲美國財政部外國資產控制辦公室當日發布一般許可1A,將可與被列入與軍方有聯繫的企業交易限期,延長至美東時間5月27日上午9時30分。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.